Rudlowski C - Search Results

1

Gemcitabine, epirubicin and docetaxel as primary systemic therapy in patients with early breast cancer: results of a multicentre phase I/II study.

Schneeweiss A, Huober J, Sinn HP, von Fournier D, Rudlowski C, Beldermann F, Krauss K, Solomayer E, Hamerla R, Wallwiener D, Bastert G. Schneeweiss A, et al. Among authors: rudlowski c. Eur J Cancer. 2004 Nov;40(16):2432-8. doi: 10.1016/j.ejca.2004.08.004. Eur J Cancer. 2004. PMID: 15519516 Clinical Trial.

2

Her-2/neu gene amplification and protein expression in primary male breast cancer.

Rudlowski C, Friedrichs N, Faridi A, Füzesi L, Moll R, Bastert G, Rath W, Büttner R. Rudlowski C, et al. Breast Cancer Res Treat. 2004 Apr;84(3):215-23. doi: 10.1023/B:BREA.0000019953.92921.7e. Breast Cancer Res Treat. 2004. PMID: 15026619

3

Only grading has independent impact on breast cancer survival after adjustment for pathological response to preoperative chemotherapy.

Schneeweiss A, Katretchko J, Sinn HP, Unnebrink K, Rudlowski C, Geberth M, Beldermann F, Bastert G, Strittmatter HJ. Schneeweiss A, et al. Among authors: rudlowski c. Anticancer Drugs. 2004 Feb;15(2):127-35. doi: 10.1097/00001813-200402000-00005. Anticancer Drugs. 2004. PMID: 15075668

4

Micrometastatic bone marrow cells at diagnosis have no impact on survival of primary breast cancer patients with extensive axillary lymph node involvement treated with stem cell-supported high-dose chemotherapy.

Schneeweiss A, Diel I, Hensel M, Kaul S, Sinn HP, Unnebrink K, Rudlowski C, Lauschner I, Schuetz F, Egerer G, Haas R, Ho AD, Bastert G. Schneeweiss A, et al. Among authors: rudlowski c. Ann Oncol. 2004 Nov;15(11):1627-32. doi: 10.1093/annonc/mdh433. Ann Oncol. 2004. PMID: 15520063 Free article.

5

Dose-dense primary systemic chemotherapy with gemcitabine plus epirubicin sequentially followed by docetaxel for early breast cancer: final results of a phase I/II trial.

Schneeweiss A, Schuetz F, Rudlowski C, Hahn M, Lauschner I, Sinn HP, von Fournier D, Sohn C. Schneeweiss A, et al. Among authors: rudlowski c. Anticancer Drugs. 2005 Oct;16(9):1023-8. doi: 10.1097/01.cad.0000176508.73090.fb. Anticancer Drugs. 2005. PMID: 16162980 Clinical Trial.

6

Gene expression signature predicting pathologic complete response with gemcitabine, epirubicin, and docetaxel in primary breast cancer.

Thuerigen O, Schneeweiss A, Toedt G, Warnat P, Hahn M, Kramer H, Brors B, Rudlowski C, Benner A, Schuetz F, Tews B, Eils R, Sinn HP, Sohn C, Lichter P. Thuerigen O, et al. Among authors: rudlowski c. J Clin Oncol. 2006 Apr 20;24(12):1839-45. doi: 10.1200/JCO.2005.04.7019. J Clin Oncol. 2006. PMID: 16622258

7

Neoadjuvant chemotherapy with carboplatin and docetaxel in advanced ovarian cancer--a prospective multicenter phase II trial (PRIMOVAR).

Pölcher M, Mahner S, Ortmann O, Hilfrich J, Diedrich K, Breitbach GP, Höss C, Leutner C, Braun M, Möbus V, Karbe I, Stimmler P, Rudlowski C, Schwarz J, Kuhn W. Pölcher M, et al. Among authors: rudlowski c. Oncol Rep. 2009 Sep;22(3):605-13. doi: 10.3892/or_00000479. Oncol Rep. 2009. PMID: 19639211 Clinical Trial.

8

HIPEC ROC I: a phase I study of cisplatin administered as hyperthermic intraoperative intraperitoneal chemoperfusion followed by postoperative intravenous platinum-based chemotherapy in patients with platinum-sensitive recurrent epithelial ovarian cancer.

Zivanovic O, Abramian A, Kullmann M, Fuhrmann C, Coch C, Hoeller T, Ruehs H, Keyver-Paik MD, Rudlowski C, Weber S, Kiefer N, Poelcher ML, Thiesler T, Rostamzadeh B, Mallmann M, Schaefer N, Permantier M, Latten S, Kalff J, Thomale J, Jaehde U, Kuhn WC. Zivanovic O, et al. Among authors: rudlowski c. Int J Cancer. 2015 Feb 1;136(3):699-708. doi: 10.1002/ijc.29011. Epub 2014 Jun 17. Int J Cancer. 2015. PMID: 24895230 Clinical Trial.

9

Sorafenib in combination with carboplatin and paclitaxel as neoadjuvant chemotherapy in patients with advanced ovarian cancer.

Pölcher M, Eckhardt M, Coch C, Wolfgarten M, Kübler K, Hartmann G, Kuhn W, Rudlowski C. Pölcher M, et al. Among authors: rudlowski c. Cancer Chemother Pharmacol. 2010 May;66(1):203-7. doi: 10.1007/s00280-010-1276-2. Epub 2010 Mar 5. Cancer Chemother Pharmacol. 2010. PMID: 20204367 Free article. Clinical Trial.

10

In vivo intratumor angiogenic treatment effects during taxane-based neoadjuvant chemotherapy of ovarian cancer.

Pölcher M, Rudlowski C, Friedrichs N, Mielich M, Höller T, Wolfgarten M, Kübler K, Büttner R, Kuhn W, Braun M. Pölcher M, et al. Among authors: rudlowski c. BMC Cancer. 2010 Apr 13;10:137. doi: 10.1186/1471-2407-10-137. BMC Cancer. 2010. PMID: 20388201 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

56 results

Search Page

Filters